Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Glyburide in Type 2 Diabetes with CHF
NCT00521820Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jun 2000
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jun 2000; status: terminated.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00521820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521820.